Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2018 Jun 5;6(8):1426-1430.
doi: 10.1002/ccr3.1595. eCollection 2018 Aug.

An ANKRD26 nonsense somatic mutation in a female with epidermodysplasia verruciformis (Tree Man Syndrome)

Affiliations
Case Reports

An ANKRD26 nonsense somatic mutation in a female with epidermodysplasia verruciformis (Tree Man Syndrome)

K M Furkan Uddin et al. Clin Case Rep. .

Abstract

Epidermodysplasia verruciformis (EV) is an extremely rare hereditary skin disease characterized by an abnormal susceptibility to the human papilloma virus (HPV) with an increased risk of cutaneous malignancy. Here we report the first female severe EV case in Bangladesh, a 10-year-old girl with a nonsense somatic mutation impacting ANKRD26 gene.

Keywords: epidermodysplasia verruciformis; nonsense mutation; somatic mutation; whole genome sequencing.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Histology and molecular profile of a female epidermodysplasia verruciformis case; A, presurgical status of nontender papulonodularor tree bark‐like lesion observed in multiple facial spots; B, histology report from immunohistochemistry on the surgically resected bark‐like lesion shows large cytoplasm characteristic to HPV and parakeratosis; C, Sanger sequencing chromatogram for DNA extracted from bark‐like tissue and D, blood showing consistently the differential pick of the mosaic stop gain mutation (T allele). E, Protein expression profile of ANKRD26,EVER1 and EVER2 from 30 developmental (prenatal to adult) human tissues. The y‐axis is the gene protein spectral count for each tissue

References

    1. Gul U, Kilic A, Gonul M, Cakmak SK, Bayis SS. Clinical aspects of epidermodysplasia verruciformis and review of the literature. Int J Dermatol. 2007;46:1069‐1072. - PubMed
    1. Leiding JW, Holland SM. Warts and all: human papillomavirus in primary immunodeficiencies. J Allergy Clin Immunol. 2012;130:1030‐1048. - PMC - PubMed
    1. Przybyszewska J, Zlotogorski A, Ramot Y. Re‐evaluation of epidermodysplasia verruciformis: reconciling more than 90 years of debate. J Am Acad Dermatol. 2017;76:1161‐1175. - PubMed
    1. Orth G. Genetics of epidermodysplasia verruciformis: insights into host defense against papillomaviruses. Semin Immunol. 2006;18:362‐374. - PubMed
    1. Ramoz N, Rueda LA, Bouadjar B, Montoya LS, Orth G, Favre M. Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis. Nat Genet. 2002;32:579‐581. - PubMed

Publication types

LinkOut - more resources